Orbimed Advisors LLC Nkarta, Inc. Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 821,400 shares of NKTX stock, worth $1.86 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
821,400
Previous 1,480,600
44.52%
Holding current value
$1.86 Million
Previous $6.69 Million
69.44%
% of portfolio
0.06%
Previous 0.16%
Shares
3 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$24.5 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$9.21 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$8.55 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$8.1 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$8.09 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $110M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...